Progression-Free Survival (PFS) is a critical endpoint in oncology clinical trials. It refers to the length of time during and after medication or treatment during which a patient lives with the disease but it does not get worse. PFS is particularly important in cancer studies as it helps evaluate the efficacy of new therapies and treatments.
